Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors.

Mengqing XieTianqing ChuXiaorong DongHuijuan WangQian ChuXiuyu CaiJialei WangYu YaoLin WuFeng YeBo ZhuCaicun ZhouChunxia Su

Published in: European journal of cancer (Oxford, England : 1990) (2024)

ICIs showed promising benefits for advanced PSC, and the addition of anti-angiogenic therapy might be a more effective treatment strategy for this disease.

Keyphrases

pulmonary hypertension
single cell
mesenchymal stem cells
combination therapy
replacement therapy